Replies to post #12762 on FDA Plays

[barefootrunner]

CLDX - hein - hard to say. A lot will depend on what they are presenting. I always try and take a conservative approach with price targets, but I think $5-$6 is certainly possible. A lot will depend on any updates they provide regarding phase 3 for rindopepimut (CDX-110), which is due to start in the second half of 2011.